Login / Signup

The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells.

Huang-Ju TuYi-Jyun LinMin-Wu ChaoTing-Yi SungYi-Wen WuYi-Ying ChenMei-Hsiang LinJing-Ping LiouShiow-Lin PanChia-Ron Yang
Published in: Clinical epigenetics (2018)
Collectively, our data highlighted that MPT0G211 in combination with chemotherapy drugs has significant anticancer activity, suggesting a novel strategy for the treatment of acute leukemia.
Keyphrases